Gong, L.; Zhao, H.; Chen, L.; Liu, Y.; Wu, H.; Liu, C.; Feng, J.; Liu, C.; Xiao, C.; Wang, Q.;
et al. Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer. Pharmaceutics 2025, 17, 246.
https://doi.org/10.3390/pharmaceutics17020246
AMA Style
Gong L, Zhao H, Chen L, Liu Y, Wu H, Liu C, Feng J, Liu C, Xiao C, Wang Q,
et al. Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer. Pharmaceutics. 2025; 17(2):246.
https://doi.org/10.3390/pharmaceutics17020246
Chicago/Turabian Style
Gong, Liming, Heming Zhao, Liqing Chen, Yanhong Liu, Hao Wu, Chao Liu, Jing Feng, Chenfei Liu, Congcong Xiao, Qiming Wang,
and et al. 2025. "Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer" Pharmaceutics 17, no. 2: 246.
https://doi.org/10.3390/pharmaceutics17020246
APA Style
Gong, L., Zhao, H., Chen, L., Liu, Y., Wu, H., Liu, C., Feng, J., Liu, C., Xiao, C., Wang, Q., Jin, M., Gao, Z., Huang, W., & Guan, Y.
(2025). Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer. Pharmaceutics, 17(2), 246.
https://doi.org/10.3390/pharmaceutics17020246
